In short
- In this piece about movement and strength, a mosquito takes centre stage: mosquitoes with two copies of a resistant form of the CYP9K1 gene reached the pupal stage faster and lived clearly longer as adults than mosquitoes without that form, so this resistance seems to cost the insect nothing.1
- After 13 generations without any insecticide at all, that resistant form was still present in roughly a third of the gene copies, while a second resistance gene, GSTe2, disappeared completely.1
- A longer mosquito life matters, because most mosquitoes do not live long enough to pass on a parasite.2
- The work was done in mosquitoes, not in people, and it says nothing about your own heart. For that question, the heart and blood vessel scan gives you a starting point; the result is not a diagnosis.
Contents
- Why a mosquito’s long life is news
- How many mosquitoes share your summer
- Why insecticides stop working
- Where the knowledge ran out
- Who found it, and where it was published
- The price of resistance, and why one gene pays nothing
- What the article showed, in whom, and what it did not show
- In short, and what you can do next for movement and strength
- Frequently asked questions
Why a mosquito’s long life is news
In this piece, you will read why mosquitoes that withstand insecticides can live longer instead of paying a price for that resistance, and why the resistance lingers for many generations after the spraying stops. That matters, because a mosquito that lives longer has more time to pass on a parasite, and because the sprays and nets that travellers and whole regions rely on work less well against such a mosquito. News about a long life is usually about people living longer. This time the news is about a mosquito that lives longer: a different story from your own movement and strength.
It is a warm evening and you have just switched off the light. Then that thin whine starts next to your ear. You switch the light back on, search the ceiling, give up and pull the sheet over your head. Or you are packing for a holiday in a warm country: sun cream, a mosquito spray, perhaps a net for the bed. You trust the spray to do its job, and you see a mosquito as a short-lived nuisance that is gone after a few days. In other parts of the world, whole villages rely on that every night, and far more depends on it than a night’s sleep.
How many mosquitoes share your summer with you

You’re not imagining the company. More than 20 species of mosquito live in the Netherlands, according to the Dutch National Institute for Public Health and the Environment (RIVM) in 2025.3 The mosquito on your bedroom wall belongs to a busy family, and you share your summer evenings with that little creature, just like everyone else in the country.
The mosquito in this piece is not a Dutch species. Anopheles funestus is found in East and Central Africa,4 and it is one of the mosquitoes that can carry a parasite that causes a serious fever in people.1 How long such a mosquito lives, and whether the insecticides used against it keep working, matters to millions of people far from here, and to every traveller who visits those regions.
Why insecticides stop working
An insecticide works as long as it kills most of the mosquitoes that come into contact with it. The few mosquitoes that survive pass on whatever made that survival possible, and over many generations that trait becomes common. One way to survive is to break the poison down before it does harm. The genes behind this are detoxification genes, and the resistance these genes give is called metabolic resistance.5
Two of those genes matter here. The first is GSTe2. In 2014, scientists showed that one single change in that gene, called L119F, gives Anopheles funestus strong resistance to the old insecticide DDT, with cross-resistance to pyrethroids. The change widens the pocket in the GSTe2 enzyme where DDT binds, so the insect breaks down more of the poison. The authors described it as the first DNA-based marker of metabolic resistance in mosquitoes.6
The second gene is CYP9K1. In 2025, a team that shares several authors with the new article showed that a single change in that gene, called G454A, lets Anopheles funestus break down pyrethroid insecticides more effectively, in East and Central Africa. The resistant form spread quickly: in 2014 it was dominant in Uganda, and in 2020 it was found in most of the mosquitoes sampled in Cameroon, 84.6 per cent of them. Mosquitoes carrying this form survived exposure to pyrethroids far more often, both in laboratory tests and in field trials in huts in Cameroon, which made bed nets work less well.4
Markers like these turned resistance into something you can count. With a DNA test, scientists can follow how resistance spreads across places and over time, judge what resistance costs the mosquito, and see what resistance does to the tools used to control mosquitoes. Metabolic resistance is more complex than other forms of resistance, which makes these tests harder to design.5
Where the knowledge ran out
For a long time, little was known about the price that metabolic resistance costs mosquitoes in the field.7 In 2018 the same group looked at field mosquitoes from Cameroon carrying the resistant GSTe2 form. Susceptible mosquitoes laid clearly more eggs than resistant ones, and the resistant mosquitoes took longer to develop and lived longer, which the authors linked to a possible rise in the spread of a parasite infection.7
For CYP9K1, the gene behind the newer wave of pyrethroid resistance, the question was still open. Does carrying this gene cost the mosquito anything? And once the insecticide is taken away, does the resistance fade by itself, or does it stay?
Who found it, and where it was published
The answer was published on 22 October 2026 in the journal Pest Management Science, under the title “Lack of fitness cost associated to CYP9K1-mediated insecticide resistance in Anopheles funestus, represents a threat to vector control”. The record lists it as a journal article, not as a preprint.1
The six authors are Manyaka-Tientcheu CRK, Tchouakui M, Djoko Tagne CS, Wondji MJ, Njiokou F and Wondji CS. All six work in the Department of Medical Entomology at the Centre for Research in Infectious Diseases (CRID) in Yaoundé, Cameroon. Several authors also hold positions elsewhere: the Laboratory of Parasitology and Ecology at the University of Yaoundé 1, the Department of Biochemistry at the University of Bamenda, and the Department of Vector Biology at the Liverpool School of Tropical Medicine in the United Kingdom.1
The authors followed two resistance genes, the CYP9K1 form and the GSTe2 form, in Anopheles funestus from Central Cameroon. The researchers measured these forms with DNA-based tests and tracked how common the resistant forms stayed across the generations.1
Why should this matter to you, reading this in the Netherlands? Because it overturns a comfortable assumption. People who plan mosquito control often expect resistance to come at a price: if you stop using an insecticide for a while, the resistant mosquitoes should lose ground and the old insecticide should become useful again. This paper suggests that hope may not hold for one important gene. It is also a reminder that a longer life is not good news for every creature. For a mosquito, a longer life means more days to bite and more chances to pass on a parasite, and the sprays and nets that travellers and health services rely on assume that resistance fades when those products are rested for a while.
The price of resistance, and why one gene pays nothing

The one idea at the heart of this article is the fitness cost. In biology, fitness does not mean being in good shape. It means how well a creature survives and leaves offspring behind. A fitness cost is the price a useful trait charges in an environment where that trait is not needed.
Think of a heavy raincoat on a dry day. In a downpour, the coat keeps you dry and every gram is worth it. On a dry day, you are slower, warmer and more tired than someone without a coat. If dry days are the norm, the people without a coat get further. Resistance genes were expected to work the same way. As long as the insecticide is everywhere, the resistant mosquito wins. Once the insecticide is gone, a mosquito carrying resistance it no longer needs was expected to fall behind, so the susceptible mosquitoes would gain the upper hand again. The authors write that removing insecticide pressure can indeed bring susceptibility back, but that the speed differs from gene to gene.1
With CYP9K1, the coat seems to weigh nothing, and may even help. Mosquitoes with two copies of the resistant CYP9K1 form reached the pupal stage, the resting stage between larva and adult mosquito, faster than mosquitoes with two susceptible copies. As adults, these mosquitoes also lived clearly longer.1 Instead of a price, the resistance came with an advantage.
The GSTe2 gene behaved differently. The resistant GSTe2 form made no clear difference to the mosquito’s life traits.1 That differs from the 2018 field work on the same gene, in which GSTe2-resistant mosquitoes laid fewer eggs and lived longer,7 and the summary of the new article does not explain the difference.
The clearest example of what this means comes from the long term. After 13 generations without any insecticide, the resistant CYP9K1 form was still present in roughly a third of the gene copies, even though no mosquito with two resistant copies was left. Sensitivity to the insecticide came back only slowly. Over the same 13 generations, the resistant GSTe2 form fell to complete absence, so the sensitivity tied to that gene came back faster.1 Two resistance genes, the same mosquitoes, the same years without spraying, and two very different outcomes.
An independent expert put it clearly why a longer life matters so much, writing in 2009 about insecticides designed to stay useful while mosquitoes evolve:
Most mosquitoes do not live long enough to pass on the disease.
Andrew Read, professor of biology and entomology, Penn State
2
Read the new paper alongside that sentence and the concern becomes clear. The authors conclude that the longer life linked to resistance may raise the chance that these mosquitoes pass on a parasite infection.1 A mosquito that survives the insecticide and also lives longer has the time most mosquitoes never get.
The article’s lead author had described the wider aim of this work years earlier, when the centre in Yaoundé received a grant to detect DNA markers of resistance:
To make control methods keep working for longer, we need to understand better how these mosquitoes build up resistance to insecticides, including the new products that the World Health Organization (WHO) is approving step by step
Charles Wondji, professor, Wellcome Trust Senior Fellow, Department of Vector Biology, Liverpool School of Tropical Medicine (LSTM); Centre for Research in Infectious Diseases (CRID), Yaoundé
8
What the paper showed, in whom, and what it did not show
What it showed: in Anopheles funestus from Central Cameroon, the resistant CYP9K1 form came with faster development and a clearly longer life as an adult mosquito, the resistant GSTe2 form made no clear difference, and after 13 generations without insecticide the CYP9K1 form stayed while the GSTe2 form disappeared. How active each of the two genes was showed no clear link with the adult mosquito’s lifespan, the larva’s development or egg-laying.1 So the advantage seems to be tied to carrying the resistant form and not to how strongly the gene is switched on, though the summary does not explain why.
In whom: mosquitoes of one species, from one region, followed over 13 generations. The abstract does not say how many mosquitoes were tested, nor how the colony was kept during those generations.
What it did not show: the article looked at mosquitoes and not at people, and says nothing about people’s health or ageing. The rise in the spread of a parasite is what the authors expect on the basis of the longer life, and the summary does not report that rise as measured. The summary reports no test at all of bed nets or sprays. The article is about one species from one region, so it does not show whether the same holds for other mosquitoes or other places.
In short, and what you can do next for movement and strength

In short: insecticides lose their power when mosquitoes inherit genes that break down the poison, and two of those genes in Anopheles funestus are CYP9K1 and GSTe2.6,4 Resistance was expected to cost the mosquito something, so it would fade once spraying stopped. The new paper in Pest Management Science found the opposite for CYP9K1: carriers developed faster and lived clearly longer, and after 13 generations without insecticide the resistant form was still present in roughly a third of the gene copies, while the GSTe2 form disappeared.1 Because most mosquitoes do not live long enough to pass on a parasite,2 the authors see the longer life as a threat to mosquito control.1 The work was done on mosquitoes from one region, the abstract does not say how many mosquitoes were used, and the rise in parasite spread was not reported as measured.
If you travel to a warm country, follow the protection advice for your destination, and do not treat a spray or a net as a promise that nothing can get through. If you have a fever and have been in a warm country in the past four weeks, call your GP the same day.9
And your own long life is a different story from the mosquito’s. This article says nothing about your heart, your movement or your strength. If you want to know how your heart and blood vessels are doing today, the scan below gives you a starting point. You can also read what moving too little does to your body and what a normal heart rate is.
Frequently asked questions
Do these mosquitoes live in the Netherlands?
There are more than 20 mosquito species in the Netherlands, the RIVM counted in 2025.3 The article looked at Anopheles funestus from Central Cameroon, a species found in East and Central Africa,4 and it says nothing about the species that live here.
Why is a longer mosquito life a problem?
A mosquito has to live long enough for a parasite to develop inside its body before that parasite can be passed on, and most mosquitoes do not live that long.2 The authors conclude that the longer life linked to CYP9K1 resistance may increase the chance that these mosquitoes pass on an infection.1 The summary does not report that increase as measured.
Does this mean bed nets no longer work?
That conclusion does not follow from this article, which did not test nets. Earlier work showed that mosquitoes with the resistant CYP9K1 form survived exposure to pyrethroids far more often, which made bed nets in Cameroon work less well.4 Nets still stop the mosquitoes that cannot get through them.
When should I call a doctor after a trip?
If you have a fever and you have been in a warm country in the past four weeks, Thuisarts advises calling your GP the same day.9
Does this say anything about my own long life?
No. The paper is about how long mosquitoes live and the genes mosquitoes use to break down insecticides.1 How your own heart and blood vessels are doing is a separate question, and a scan gives you insight and is not a diagnosis.
Sources
Every source below was checked on the day this article was published. The numbering follows the text.
- Manyaka-Tientcheu CRK, Tchouakui M, Djoko Tagne CS, Wondji MJ, Njiokou F, Wondji CS. Lack of fitness cost associated to CYP9K1-mediated insecticide resistance in Anopheles funestus, represents a threat to vector control. Pest Management Science, 2026. doi.org/10.1002/ps.71270
- Andrew Read, professor of biology and entomology, Penn State. Evolution-Proof Insecticides May Stall Malaria Forever. Penn State Eberly College of Science, 2009. science.psu.edu
- RIVM. Frequently asked questions about the Asian tiger mosquito. 2025. rivm.nl
- Djoko Tagne CS, Kouamo MFM, Tchouakui M, et al., Wondji C. A single mutation G454A in the P450 CYP9K1 drives pyrethroid resistance in the major malaria vector Anopheles funestus reducing bed net efficacy. Genetics, 2025. doi.org/10.1093/genetics/iyae181
- Tchouakui M, Djoko Tagne CS, Tekoh TA, Tatchou-Nebangwa NMT, Kouamo MM, Wondji CS. Metabolic insecticide resistance DNA markers in malaria vectors. Trends in Parasitology, 2026. doi.org/10.1016/j.pt.2026.03.013
- Riveron JM, Yunta C, Ibrahim SS, Djouaka R, Irving H, Menze BD, Ismail HM, Hemingway J, Ranson H, Albert A, Wondji CS. A single mutation in the GSTe2 gene allows tracking of metabolically based insecticide resistance in a major malaria vector. Genome Biology, 2014. doi.org/10.1186/gb-2014-15-2-r27
- Tchouakui M, Riveron JM, Djonabaye D, Tchapga W, Irving H, Soh Takam P, Njiokou F, Wondji CS. Fitness Costs of the Glutathione S-Transferase Epsilon 2 (L119F-GSTe2) Mediated Metabolic Resistance to Insecticides in the Major African Malaria Vector Anopheles Funestus. Genes (Basel), 2018. doi.org/10.3390/genes9120645
- Charles Wondji, Professor and Wellcome Trust Senior Fellow, Department of Vector Biology, Liverpool School of Tropical Medicine. CRID awarded grant for the detection of molecular markers of insecticide resistance in malaria vectors. LSTM, 2020. lstmed.ac.uk
- Thuisarts.nl. I have a fever: what can help and is it dangerous? 2026. thuisarts.nl
Quotations from English have been translated by BioProfile.
Also read
See where your heart stands today
The heart and blood vessel scan gives you a picture of where you stand today, as a starting point for your own choices. The scan is not a diagnosis.
Free, about 3 minutes. An analysis of your answers, never a diagnosis.
BioProfile analyses your health status to guide you and your coach. It does not make a diagnosis, only a doctor can do that. Built on validated health questionnaires; the combined BioProfile score is not itself a validated clinical instrument yet. Your answers stay private (GDPR).
